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Aberrations in the phospbatidylinositol3-kinase (PI3K)IAkt pathway have been found in 
a wide spectrum of human cancers. Activation of Akt and inactivation of the 
downstream substrates such as GSK-3P, BAD and Forkhead family (FKHR) proteins are 
relevant to promote cell survival, proliferation and growth. Another related pathway 
linked with PI3K/Akt is the Ras/Raf/MEK/ERK, which is known to promote cancer as a 
result of ras-transformation. The discovery of new drugs targeted at specific molecules 
of these pathways is a 'hot' field in cancer research. Blocking the constitutively active 
PI3WAkt pathway provides a new strategy for cancer therapy. Thus, inhibitors of this 
signaling pathway would be potential anti-cancer agents. The Streptomyces strain H7372 
isolated h m  mangrove soils in Sabah was found to inhibit the Ras/Raf-1 protein 
interaction in the yeast two-hybrid screening system. The present study was undertaken 
to determine the cytotoxic effect of H7372 hctionated extract on a breast cancer cell 
line, MCF-7 and a non-tumorigenic epithelial cell line, MCF-1OA and quantitatively 
measure kinase inhibition, apoptosis induction and cell cycle disruption. The crude 
iii 
extracts of H7372 were fractionated into eight Eractions using reverse phase HPLC. 
Fraction 5 was found to be the most cytotoxic in an M'IT assay. The crude extract and 
fraction 5 of H7372 were found to exert growth inhibition of MCF-7 at ICS0 of 1 5 & n l  
and 1.4 pglml, respectively. Western blot analyses showed that activated PI3K and Akt 
(Thr308) but not Akt (Ser473) by stimulation of IGF-I were inhibited by the crude 
extract and fraction 5 after 72 hours. Interestingly, phosphorylation of Raf-1 (Ser259) 
and ERKl were also inhibited by fraction 5, indicated that there is a cross-talk between 
PI3WAkl and MAPK pathways. By using the flow cytometry technique, we found that 
fraction 5 inhibited the proliferation of MCF-7 cell line by causing them to arrest in the 
GI phase of the cell cycle. The induction of growth arrest by fraction 5 was associated 
with accumulation of cells in GI and decreasing cells in S and G2/M phases. The results 
were supported by inihibition of cyclin Dl in MCF-7 cells. The apoptosis study showed 
that fraction 5 but not crude extract was increased the percentage of cells in early 
apoptotic stage at all concentrations. Furthermore, treatment of MCF-7 cells with 
fraction 5 resulted in reduction in phosphorylation of GSK-3$ (Ser9), phospho-BAD 
(Serll2) and phospho-FKHR (Ser256). These results could contribute the apoptosis in 
MCF-7 cell line. Thus, we discovered that k t i o n  5 of H7372, a naturally occurring 
microbe, contains an inhibitor of cell proliferation, cell cycle progression and is able to 
induce apoptosis via the PI3WAkl and MAPK pathways. 
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memenuhi keperluan untuk ijazah Master Sains 
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Pembatan dan Sains Kesihatan 
Gan%guan dalam lintasan phosphatidylinositol 3-kinase (PI3KYAkt (Protein Kinase B) 
telah ditemui secara meluas di ddam kanser manusia Pengaktifan Akt d m  
- - - --- - - - - -  . 
penyahaktifan substrat bawahan seperti protein GSK-3fl, BAD and Forkhead family 
(FKHR) adalah berkaitan bagi pemanjangan hayat, penambahan dan perhunbuhan sel. 
Lintasan lain yaag berkaitan dengan PI3WAkt adalah RadWMEWERK di mana ia 
telah dikenalpasti bagi menyebabkan kanser yang disebabkan oleh transformasi raf. 
Penemuan ubat-ubatan baru bagi sasaran molekul yang spesifik untuk lintasan ini adalah 
bidang yang hangat dalam kajian kanser. Penghalangan lintasan PI3KIAkt yang aktif 
berterusan memberi starategi baru untuk tempi kanser. Oleh itu, perencat lintasan isyarat 
ini akan menjadi agen mthnser yang berpotensi. Streptomyces strain H7372 yang 
diasiqgkan daripada tanah paya bakau di Sabah telah merencat interaksi protein RaJ/Raf- 
1 di dalam sistern penyaringau 'yeast two-hybrid'. Kajian ini telah dilakukan untuk 
menentukau kesan sitotoksik oleh ekstrak H7372 yang telah ditkaksi krhadap sel kanser 
payudara, MCF-7 dan sel epithelium bukan tumor, MCF-lOA, serta mengukur secara 
kuantiti perencatan kinase, induksi apoptosis clan pemusnahan kitaran sel. Ekstrak 
mentah H7372 telah difraksikan kepada lapan h k s i  menggunakan fasa berbalik HPLC. 
Fraksi ke-5 telah dikenalpasti sebagai fhksi yang paling sitotoksik di dalam asei MlT. 
Ekstrak mentah telah dikenalpasti dapat merencat pertumbuhan pada ICso15pg/ml 
manakala, fiaksi ke-5 pada 1.4 pg/ml. Analisis dari kaedah 'Western blot' telah 
menunjukkan bahawa pengaktifan PI3K dan Akt (Thr308) tetapi bukan Akt (Ser473) 
dengan rangsangan IGF-I telah direncat oleh ekstrak mentah dan fhksi ke-5 selepas 72 
jam. Fosforilasi Raf-1 (ser259) dan ERK 112 juga telah direncat oleh fraksi ke-5 dan 
ianya menunjukkan bahawa terdapatnya hubungan antara lintasan PI3WAkt dan lintasan 
MAPK. Dengan menggunakan teknik 'flow cytometry', kami mendapati bahawa m i  
ke-5 telah merencat penambahan sel MCF-7 dan dengan ini menyebabkan sel tersebut 
ditahan pada fasa GI di dalarn kitaran sel. Induksi bagi penahanan pertumbuhan oleh 
f k b i  ke-5 telah menyebabkan pengumpulan sel di dalam fasa GI dan mengurangkan 
jumlah sel di dalarn fasa S dan Gm. Keputusan-keputusan ini telah disokong oleh 
perencatan cyclin Dl dalam sel MCF-7. Kajian apoptosis telah menunjukkan bahawa 
fraksi ke-5 tetapi bukan ekstrak mentah telah meningkatkan peratusan sel pada tahap 
awal apoptosis bagi setiap kepekatan. Tambahan pula, rawatan sel MCF-7 oleh fraksi 
ke-5 telah menyebabkan penurunan di dalam fosforilasi GSK-3 $ (Ser9), BAD (Serll2) 
dan FKHR (Ser256). Keputusan-keputusan ini boleh menyumbmg kepada apoptosis 
bagi sel MCF-7. Oleh itu, kajian ini telah mengenalpasti bahawa fraksi ke-5 daripada 
mikroorganisma semulajadi mengandungi perencat bagi penmbahan sel, progresi 
kitaran sel clan juga berupaya untuk merangsang apoptosis melalui lintasan PI3WAkt 
dan MAPK. 
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mean & 1 SD bar, *, indicate significantly greater than control, p < 
0.05. 
Effects of fraction 5 on the cell cycle profile. Histogram shows the 
phases in the cell cycle: G1 (MI); S (M2); G m  (M3) and Sub-GI 
(M4). The MCF-1OA cells were cultured in medium alone as a 
control or cultured in the presence of fiaction 5 in various 
concentrations for (A) 24 hours, (B) 48 hours and (C) 72 hours. I; 
Control, 11; 0.7 pg/mL fkaction 5,111; 1.4 pg/mL fraction 5, IV; 2.8 
pg/mL fiaction 5. 
Percentage of MCF-IOA cells in GI phase treated with k t i o n  5 
based on DNA content in two independent experiments. The 
percentage of cells in GI phase which were treated with the fiaction 
5 shows no significant increase at all incubation period compared to 
the mtmated cells (control). The results shown were mean It 1 SD 
bar. 
Percentage of MCF-1OA cells in S phase treated with fraction 5 
based on DNA content in two independent experiments. The 
percentage of cells in S phase which were treated with the fraction 5 
shows significant decrease after 24h incubation period compared to 
the untreated cells (control). The results shown were mean k 1 SD 
bar. *, indicate significantly lower than control, p < 0.05. 
Percentage 
based on 
of MCF-1OA cells in G2/M phase treated with fraction 5 
DNA content in two independent experiments. The 
of cells in G & f  phase which were treated with the 
shows significant decrease at 2.8pg/mL after 48h 
incubation period compared to the untreated cells (control). The 
results shown were mean 1 SD bar. *, indicate significantly lower 
than control, p < 0.05. 
Percentage of MCF-1OA cells in Sub-GI phase treated with &tion 
5 based on DNA content in two independent experiments. The 
percentage of cells in Sub-GI phase which were treated with the 
fraction 5 have no significant different at all incubation period 
compared to the untreated cells (control). The results shown were 
mean & 1 SD bar. 
Effects of k t i o n  5 on cyclin Dl. MCF-7 cell line was with and 
without k t i o n  5 at various concentrations for 72 hours and 
stimulated with IGF-I. 
Comparison line chart on the normalized level of expression of 
cyclin Dl as compared to baseline pactin. The expression level of 
cyclii Dl was decreased by h t i o n  5 in a dose-dependent manner. 
Graphical data represent the MCF-7 cell line was treated and 
untreated with fiaction 5 in various concentrations for 72 hours. 
MCF-7 treated with H7372 for 24 hours. The cells were stained with 
Annexin V and PI. I; 0 pg/mL H7372,II; 7.5 &mL H7372, III; 15 
pg/mL H7372, IV; 30 pg/mL H7372. 
MCF-7 treated with H7372 for 48 hours. The cells were stained with 
Annexin V and PI. I; 0 pg/mL H7372,II; 7.5 pg/mL H7372,III; 15 
pg/mL H7372, IV; 30 pg/mL H7372. 
MCF-7 treated with H7372 for 72 hours. The cells were stained with 
Annexin V and PI. I; 0 pg/mL H7372,II; 7.5 p g l d  H7372, III; 15 
pg/mL H7372, IV; 30 pghL H7372. 
4.38 Percentage of (A) early apoptotic cells, (B) late apoptotic cells, and 102 
(C) necrotic cells in two independent experiments. MCF-7 cells 
were treated with crude extracts of H7372 at indicated time and 
concentrations. The results shown were mean k 1 SD bar. *, indicate 
significantly greater than control, p < 0.05. 
4.39 MCF-7 treated with W o n  5 for 24 hours. The cells were stained 
with Annexin V and PI. I; 0 pg/mL fraction 5, II; 0.7 pg/rnL fraction 
5,111; 1.4 pg/mL fraction 5, IV; 2.8 pg/mL fkaction 5. 
4.40 MCF-7 treated with fiaction 5 for 48 hours. The cells were stained 
with Annexin V and PI. I; 0 &mL fhction 5,II; 0.7 pg/mL fraction 
5,111; 1.4 pg/mL W o n  5, IV; 2.8 pg/mL fraction 5. 
MCF-7 treated with fraction 5 for 72 hours. The cells were stained 
with Annexin V and PI. I; 0 pg/mL fraction 5,II; 0.7 p g / d  fraction 
5,111; 1.4 pg/mL fraction 5, IV; 2.8 p g / d  fraction 5. 
Percentage of (A) early apoptotic cells, (B) Zate apoptotic cells, and 
(C) necrotic cells in two independent experiments. MCF-7 cells 
were treated with hction 5 at indicated time and concentrations. 
The results shown were mean k 1 SD bar. *, indicate significantly 
greater than control, p < 0.05. 
MCF-1OA treated with W o n  5 for 24 hours. The cells were 
stained with Annexin V and PI. I; Opg/mL fraction 5, II; 0.7 pg/mL 
frsiction 5,111; 1.4 pg/mL hction 5, IV; 2.8 pg/mL Man 5. 
MCF-1OA treated with fraction 5 for 48 hours. The cells were 
stained with Annexin V and PI. I; Opg/mL fraction 5,II; 0.7 pg/mL 
fraction 5,111; 1.4 pg/mL W o n  5, IV; 2.8 p g / d  fraction 5. 
MCF-1OA treated with W o n  5 for 72 hours. The cells were 
stained with Annexin V and PI. I; Opg/mL fraction 5, 11; 0.7 pg/mL 
fraction 5,111; 1.4 pg/mL h t i o n  5, IV; 2.8 pg/mL fraction 5. 
Percentage of (A) early apoptotic cells, (B) late apoptotic cells, and 
(C) necrotic cells. MCF-1OA cells were treated with fiaction 5 at 
indicated time and concentrations. 
Regulation of the GI/S phase transition (Adapted from Roy and 
Thompson, 2006). 
LIST OF ABBREVIATIONS 
Approximately 
Percentage 
Alpha 
Beta 
Gamma 
Kappa 
Micro 
Centimetre 
Degree of Celsius 
Carbon dioxide 
Gram 
Kilo Dalton 
Liter 
Molar 
Miligram 
Minute 
Milliliter 
Millimetre 
Nanogram 
Revolutions per minute 
Microgram 
Microliter 
w 
u 
v 
AMP 
A P S  
ATCC 
BSA 
CDK 
DNA 
DTT 
EGF 
ERK 
FGF 
FITC 
GSK-3$ 
HC1 
HPLC 
Hsp90 
IDV 
IGF 
IGF-R 
ILK 
IR 
IRS 
Micrometer 
International unit 
Volt 
Adenosine monophosphate 
Ammonium persulphate 
American Type Cell Collection 
Bovine serum albumin 
Cyclin dependent kinase 
Deoxyribonucleic acid 
Dithioretol 
Epidermal growth factor 
Extracellular signal regulated kinase 
Fibroblast growth factor 
Fluorescein isothiocyanate 
Glycogen synthase kinase-3Betta 
Hydrochloride acid 
High performance liquid chromatography 
Heat shock protein 90 
Integrated density value 
Insulin-like growth factor 
Insulin-like growth factor-I receptor 
lntegrin-linked lcinase 
Insulin receptor 
Insulin-response sequence 
